Area of research
Oncology · Radiology, Nuclear Medicine and Imaging
Research interest
Research interests include PARP inhibition in cancer therapy, Glioma Diagnosis and Treatment, Radiopharmaceutical Chemistry and Applications, and Cell Adhesion Molecules Research.
PARP1-targeted fluorescence molecular endoscopy as novel tool for early detection of esophageal dysplasia and adenocarcinoma
Actionable loss of SLF2 drives B‐cell lymphomagenesis and impairs the DNA damage response
The OTUD6B‐LIN28B‐MYC axis determines the proliferative state in multiple myeloma
A phase I study of a PARP1-targeted topical fluorophore for the detection of oral cancer
Targeted Brain Tumor Radiotherapy Using an Auger Emitter
Optical Imaging Modalities: Principles and Applications in Preclinical Research and Clinical Settings
Validation of the use of a fluorescent PARP1 inhibitor for the detection of oral, oropharyngeal and oesophageal epithelial cancers
Positron-Emission Tomographic Imaging of a Fluorine 18–Radiolabeled Poly(ADP-Ribose) Polymerase 1 Inhibitor Monitors the Therapeutic Efficacy of Talazoparib in SCLC Patient–Derived Xenografts
Inhibiting Inflammation with Myeloid Cell-Specific Nanobiologics Promotes Organ Transplant Acceptance
Target engagement imaging of PARP inhibitors in small-cell lung cancer
Molecular Imaging of PARP
Detection and delineation of oral cancer with a PARP1 targeted optical imaging agent
Non-invasive PET Imaging of PARP1 Expression in Glioblastoma Models
Dual-Modality Optical/PET Imaging of PARP1 in Glioblastoma